Ledger.Open graph →
SEC Form D · filed February 5, 2024

Kura Oncology, Inc

Offering
$150.0M
Sold
$150.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Teresa Bair · SAN DIEGO, CAExecFaheem Hasnain · San Diego, CADirectorHelen Collins · SAN DIEGO, CADirectorMary Szela · Watertown, MADirectorTroy Wilson · LA JOLLA, CAExec · DirectorDiane Parks · SAN DIEGO, CADirectorBrian Powl · SAN DIEGO, CAExecThomas Malley · Ventura, CADirectorKathleen Ford · Chicago, ILExecCarol Schafer · SAN DIEGO, CADirectorStephen Dale · SAN DIEGO, CAExecDiane Parks · SAN DIEGO, CADirectorTeresa Bair · SAN DIEGO, CAExecFaheem Hasnain · San Diego, CADirectorHelen Collins · SAN DIEGO, CADirectorBrian Powl · SAN DIEGO, CAExecThomas Malley · SAN DIEGO, CADirectorMary Szela · Watertown, MADirectorKathleen Ford · Chicago, ILExecCarol Schafer · SAN DIEGO, CADirectorTroy Wilson · LA JOLLA, CAExec · DirectorStephen Dale · SAN DIEGO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗